Rifampin: mechanisms of action and resistance
- PMID: 6356275
- DOI: 10.1093/clinids/5.supplement_3.s407
Rifampin: mechanisms of action and resistance
Abstract
Rifampin specifically inhibits bacterial RNA polymerase, the enzyme responsible for DNA transcription, by forming a stable drug-enzyme complex with a binding constant of 10(-9) M at 37 C. The corresponding mammalian enzymes are not affected by rifampin. Bacterial resistance to rifampin is caused by mutations leading to a change in the structure of the beta subunit of RNA polymerase. Such resistance is not an all-or-nothing phenomenon; rather, a large number of RNA polymerases with various degrees of sensitivity to rifampin have been found. No strict correlation exists between enzyme sensitivity and MIC values, since inhibition of RNA synthesis does not always show up to the same extent in the two different test systems used for the determination of these values.
Similar articles
-
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.Antimicrob Agents Chemother. 2000 Nov;44(11):3163-6. doi: 10.1128/AAC.44.11.3163-3166.2000. Antimicrob Agents Chemother. 2000. PMID: 11036042 Free PMC article.
-
Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.Antimicrob Agents Chemother. 2005 Apr;49(4):1587-90. doi: 10.1128/AAC.49.4.1587-1590.2005. Antimicrob Agents Chemother. 2005. PMID: 15793146 Free PMC article.
-
[Nucleotide substitutions in the rpoB gene leading to rifampicin resistance of E. coli RNA polymerase].Bioorg Khim. 1984 Jan;10(1):127-8. Bioorg Khim. 1984. PMID: 6385989 Russian.
-
Resistance to rifampicin: a review.J Antibiot (Tokyo). 2014 Sep;67(9):625-30. doi: 10.1038/ja.2014.107. Epub 2014 Aug 13. J Antibiot (Tokyo). 2014. PMID: 25118103 Review.
-
Mutational analysis of structure-function relationship of RNA polymerase in Escherichia coli.Methods Enzymol. 1996;273:300-19. doi: 10.1016/s0076-6879(96)73027-6. Methods Enzymol. 1996. PMID: 8791620 Review. No abstract available.
Cited by
-
Combating antimicrobial resistance: the silent war.Front Pharmacol. 2024 Feb 14;15:1347750. doi: 10.3389/fphar.2024.1347750. eCollection 2024. Front Pharmacol. 2024. PMID: 38420197 Free PMC article. Review.
-
Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli.Microbiol Spectr. 2024 Jan 11;12(1):e0289523. doi: 10.1128/spectrum.02895-23. Epub 2023 Dec 6. Microbiol Spectr. 2024. PMID: 38054714 Free PMC article.
-
The Controversial Effect of Antibiotics on Methicillin-Sensitive S. aureus: A Comparative In Vitro Study.Int J Mol Sci. 2023 Nov 14;24(22):16308. doi: 10.3390/ijms242216308. Int J Mol Sci. 2023. PMID: 38003500 Free PMC article.
-
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.MMWR Recomm Rep. 2023 Nov 17;72(6):1-47. doi: 10.15585/mmwr.rr7206a1. MMWR Recomm Rep. 2023. PMID: 37963097 Free PMC article.
-
Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients.Antibiotics (Basel). 2023 Sep 30;12(10):1499. doi: 10.3390/antibiotics12101499. Antibiotics (Basel). 2023. PMID: 37887200 Free PMC article.